[go: up one dir, main page]

GR1001220B - Cytokine and hormone carriers for conjugate vaccines - Google Patents

Cytokine and hormone carriers for conjugate vaccines

Info

Publication number
GR1001220B
GR1001220B GR900100595A GR900100595A GR1001220B GR 1001220 B GR1001220 B GR 1001220B GR 900100595 A GR900100595 A GR 900100595A GR 900100595 A GR900100595 A GR 900100595A GR 1001220 B GR1001220 B GR 1001220B
Authority
GR
Greece
Prior art keywords
cytokine
hormone
conjugate vaccines
lymphokine
hormone carriers
Prior art date
Application number
GR900100595A
Other languages
Greek (el)
Other versions
GR900100595A (en
Inventor
Eby Ronald
Pillai Subramonia
Original Assignee
Praxis Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Praxis Biolog Inc filed Critical Praxis Biolog Inc
Publication of GR900100595A publication Critical patent/GR900100595A/en
Publication of GR1001220B publication Critical patent/GR1001220B/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η εφεύρεση αυτή αφορά ανοσογονικά προϊόντα σύζευξης που περιλαμβάνουν ένα αντιγόνο που περιέχει υδατάνθρακα ή άλλο αντιγόνο συνδεδεμένο ή γενετικά συντηγμένο με μία κυτοκίνη, λεμφοκίνη, ορμόνη ή παράγοντα ανάπτυξης, που έχει ανοσορυθμιστική δραστικότητα, όπου η κυτοκίνη, λεμφοκίνη, ορμόνη ή παράγων ανάπτυξης είναι ικανοί να τροποποιούν την ανοσογονικότητα του αντιγόνου που περιέχει υδατάνθρακα. Η κυτοκίνη ή λεμφοκίνη, μπορεί να είναι μία ιντερλευκίνη ή μία ιντερφερόνη. Το ανοσογονικό προϊόν σύζευξης μπορεί να χρησιμοποιείται σε συνταγές εμβολίου και συνταγές συν- εμβολίου. ωThis invention relates to immunogenic conjugates comprising a carbohydrate-containing antigen or other antigen linked or genetically fused to a cytokine, lymphokine, hormone or growth factor, having immunomodulatory activity, wherein the cytokine, lymphokine, hormone or growth factor is capable of modify the immunogenicity of the carbohydrate-containing antigen. The cytokine, or lymphokine, can be an interleukin or an interferon. The immunogenic conjugate can be used in vaccine formulations and co-vaccine formulations. oh

GR900100595A 1990-08-06 1990-08-06 Cytokine and hormone carriers for conjugate vaccines GR1001220B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR90100595 1990-08-06

Publications (2)

Publication Number Publication Date
GR900100595A GR900100595A (en) 1992-08-31
GR1001220B true GR1001220B (en) 1993-06-21

Family

ID=10940198

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100595A GR1001220B (en) 1990-08-06 1990-08-06 Cytokine and hormone carriers for conjugate vaccines

Country Status (1)

Country Link
GR (1) GR1001220B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
ZA875681B (en) * 1986-08-01 1988-04-27 Commw Scient Ind Res Org Recombinant vaccine
US4879374A (en) * 1987-03-13 1989-11-07 Immunex Corporation Bovine interleukin-1β DNA sequence
EP0420913B1 (en) * 1988-06-14 1995-11-15 Cell Med, Inc. Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same

Also Published As

Publication number Publication date
GR900100595A (en) 1992-08-31

Similar Documents

Publication Publication Date Title
IL102687A (en) Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
FI903292A0 (en) T-CELLEPITOP SOM BAERARMOLEKYLER FOER KJJUGERADE VACCINER.
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
ES2188583T3 (en) POLYPEPTIDES FOR HEPATITIS C VIRUS (HCV).
SE7613851L (en) GLUCOSAMINE DERIVATIVES
EP0668781A4 (en) LYMPHOKINE GENTHERAPY IN CANCER.
ATE188737T1 (en) E.COLI P-FIMBRIAE AS AN IMMUNOGENIC CARRIER AGAINST GNRH
DK120383A (en) PROCEDURE FOR THE PREPARATION OF HAPTEN AND MURAMYL PEPTID CONJUGATES THAT HAVE THE IMMUNOGENIC EFFECT
IL123264A0 (en) Multi-subtype FIV vaccines
CY1105010T1 (en) PEPTIDES DERIVED FROM THE BINDING (G) PROTEIN OF RESPIRATORY SYNDICATE VIRUS
DE4192786T1 (en) Measles Virus Recombinant Smallpox Virus Vaccine
GR1001220B (en) Cytokine and hormone carriers for conjugate vaccines
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
ES2079851T3 (en) USE OF IL-4 TO IMPROVE THE IMMUNE RESPONSE AGAINST IMMUNOGEN IN VACCINES.
NO307815B1 (en) Live or inactivated parental vaccine against rotavirus infection
BR9306187A (en) Bacterin-toxoid vaccine pasteurella haemolytica type a-1
NO920160L (en) CYTOCHINE AND HORMONABERS FOR CONJUGATE VACCINES
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
ATE99955T1 (en) IMMUNOLOGICALLY ACTIVE PEPTIDE CONJUGATE PPD-(NANP)N USE AS AN ANTI-MALARIA VACCINE.
IT1233419B (en) IMMUNOLOGICALLY ACTIVE SYNTHETIC PEPTIDES USEFUL FOR THE PREPARATION OF AN ANIMALARY VACCINE
GR1000251B (en) Polypeptidic series immunologically active
FR2698271B1 (en) Bovine leukemia virus vaccine, new immunogenic peptide and vaccination kit.
AU8762591A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
FR2685333B1 (en) NEW PEPTIDE IN PARTICULAR FOR THE REALIZATION OF ANTI-LHRH IMMUNOGENIC CONJUGATES, VACCINES INCORPORATING THEM AND VACCINATION PACKAGE RELATING THEREOF.